APOP - セレクト・バイオテクノロジ― (Cellect Biotechnology Ltd.) セレクト・バイオテクノロジ―

 APOPのチャート


 APOPの企業情報

symbol APOP
会社名 Cellect Biotechnology Ltd (セレクト・バイオテクノロジ―)
分野(sector)   
産業(industry)   
業種    医療関連(Health Care)
概要 事業概要 --   セレクト・バイオテクノロジ―はイスラエルのバイオ医薬品企業。主に、免疫細胞治療、幹細胞治療、再生医療の開発に従事する。同社のプラットフォ―ムは幹細胞の特性に基づき、アポト―シス(細胞死)誘導エ―ジェントを開発する。動物実験では成果があり、今後は臨床試験やパイプラインの開発に取り組む。本社はクファ―ルサバ。   Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.
本社所在地 23 Ha'Taas St. Kfar Saba ISR
代表者氏名
代表者役職名
電話番号
設立年月日
市場名 NASDAQ Small Cap
ipoyear 2016年
従業員数
url www.cellectbio.com
nasdaq_url https://www.nasdaq.com/symbol/apop
adr_tso 6468992
EBITDA EBITDA ー
終値(lastsale) 4.8073
時価総額(marketcap) 31098385.2416
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 APOPのテクニカル分析


 APOPのニュース

   Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying  2020/05/11 15:46:06 Benzinga
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) were advancing strongly Monday. Why Cellect Bio Is Rallying The Tel Aviv, Israel-based company announced the publication in the peer-reviewed medical journal Bone Marrow Transplantation of an article entitled "Ex-vivo FAS-ligand to Improve Allograft Safety," which highlighted pre-clinical research findings that engraftment is robust following transplantation of treated graft. The graft retained its immune reconstitution and anti-leukemic effects, the company said. Cellect said it has initiated a Phase 1/2 study in adults undergoing stem cell transplant for the treatment of hematological malignancies. … Full story available on Benzinga.com
   A Strong But Cautious Start To The Second Quarter  2020/04/17 18:03:49 Benzinga Feeds
After a bumpy first qurster to 2020, I’ve finally found some strong footing for my day trading in April. As of this writing, I’m coming off of 11 straight green days totaling about $30,000 in my main trading account. That also means, after some significant drawdowns, my trading account is back up at all-time highs. While I managed to get this streak going in the first week of April with several solid wins in Cellect Biotechnology Ltd. (NASDAQ: APOP ) Safe-T Group Ltd. (NASDAQ: SFET ), most of my winning trades that week were at or under $1,000. This was largely due to me taking on smaller share size as a result of the rocky results I’d been seeing through February and March. However, things really turned around as momentum began … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   Nano-Cap Cellect Biotechnology Rips Higher On Medical Cannabis Deal  2020/03/04 16:20:12 Benzinga
Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) are advancing strongly Wednesday. The Israeli company said it has entered into a commercial binding Letter of Intent with medical cannabis company Cannadoc to acquire all rights to the use of Cannadoc products for the reduction of opioid use, including accumulated data as well as ongoing and pipeline of clinical trials. Cellect has developed a technology platform called ApoGraft that selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies, while Cannadoc is a pharma grade medical cannabis company. The agreement also provides for … Full story available on Benzinga.com
   Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid Usage  2020/03/04 13:00:00 PR Newswire
/PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today…
   Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying  2020/05/11 15:46:06 Benzinga
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) were advancing strongly Monday. Why Cellect Bio Is Rallying The Tel Aviv, Israel-based company announced the publication in the peer-reviewed medical journal Bone Marrow Transplantation of an article entitled "Ex-vivo FAS-ligand to Improve Allograft Safety," which highlighted pre-clinical research findings that engraftment is robust following transplantation of treated graft. The graft retained its immune reconstitution and anti-leukemic effects, the company said. Cellect said it has initiated a Phase 1/2 study in adults undergoing stem cell transplant for the treatment of hematological malignancies. … Full story available on Benzinga.com
   A Strong But Cautious Start To The Second Quarter  2020/04/17 18:03:49 Benzinga Feeds
After a bumpy first qurster to 2020, I’ve finally found some strong footing for my day trading in April. As of this writing, I’m coming off of 11 straight green days totaling about $30,000 in my main trading account. That also means, after some significant drawdowns, my trading account is back up at all-time highs. While I managed to get this streak going in the first week of April with several solid wins in Cellect Biotechnology Ltd. (NASDAQ: APOP ) Safe-T Group Ltd. (NASDAQ: SFET ), most of my winning trades that week were at or under $1,000. This was largely due to me taking on smaller share size as a result of the rocky results I’d been seeing through February and March. However, things really turned around as momentum began … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   Nano-Cap Cellect Biotechnology Rips Higher On Medical Cannabis Deal  2020/03/04 16:20:12 Benzinga
Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) are advancing strongly Wednesday. The Israeli company said it has entered into a commercial binding Letter of Intent with medical cannabis company Cannadoc to acquire all rights to the use of Cannadoc products for the reduction of opioid use, including accumulated data as well as ongoing and pipeline of clinical trials. Cellect has developed a technology platform called ApoGraft that selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies, while Cannadoc is a pharma grade medical cannabis company. The agreement also provides for … Full story available on Benzinga.com
   Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid Usage  2020/03/04 13:00:00 PR Newswire
/PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today…
   Why Israeli Stem Cell Therapy Company Cellect Biotech Is Rallying  2020/05/11 15:46:06 Benzinga
Shares of nano-cap stem cell therapy company Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) were advancing strongly Monday. Why Cellect Bio Is Rallying The Tel Aviv, Israel-based company announced the publication in the peer-reviewed medical journal Bone Marrow Transplantation of an article entitled "Ex-vivo FAS-ligand to Improve Allograft Safety," which highlighted pre-clinical research findings that engraftment is robust following transplantation of treated graft. The graft retained its immune reconstitution and anti-leukemic effects, the company said. Cellect said it has initiated a Phase 1/2 study in adults undergoing stem cell transplant for the treatment of hematological malignancies. … Full story available on Benzinga.com
   A Strong But Cautious Start To The Second Quarter  2020/04/17 18:03:49 Benzinga Feeds
After a bumpy first qurster to 2020, I’ve finally found some strong footing for my day trading in April. As of this writing, I’m coming off of 11 straight green days totaling about $30,000 in my main trading account. That also means, after some significant drawdowns, my trading account is back up at all-time highs. While I managed to get this streak going in the first week of April with several solid wins in Cellect Biotechnology Ltd. (NASDAQ: APOP ) Safe-T Group Ltd. (NASDAQ: SFET ), most of my winning trades that week were at or under $1,000. This was largely due to me taking on smaller share size as a result of the rocky results I’d been seeing through February and March. However, things really turned around as momentum began … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   Nano-Cap Cellect Biotechnology Rips Higher On Medical Cannabis Deal  2020/03/04 16:20:12 Benzinga
Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP ) are advancing strongly Wednesday. The Israeli company said it has entered into a commercial binding Letter of Intent with medical cannabis company Cannadoc to acquire all rights to the use of Cannadoc products for the reduction of opioid use, including accumulated data as well as ongoing and pipeline of clinical trials. Cellect has developed a technology platform called ApoGraft that selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies, while Cannadoc is a pharma grade medical cannabis company. The agreement also provides for … Full story available on Benzinga.com
   Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid Usage  2020/03/04 13:00:00 PR Newswire
/PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today…

 関連キーワード  (― 米国株 セレクト・バイオテクノロジ― APOP Cellect Biotechnology Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)